172 related articles for article (PubMed ID: 35894278)
21. APOL1 at 10 years: progress and next steps.
Freedman BI; Kopp JB; Sampson MG; Susztak K
Kidney Int; 2021 Jun; 99(6):1296-1302. PubMed ID: 33794228
[TBL] [Abstract][Full Text] [Related]
22. APOL1 nephropathy - a population genetics success story.
Tabachnikov O; Skorecki K; Kruzel-Davila E
Curr Opin Nephrol Hypertens; 2024 Jul; 33(4):447-455. PubMed ID: 38415700
[TBL] [Abstract][Full Text] [Related]
23. APOL1 Nephropathy: A Population Genetics and Evolutionary Medicine Detective Story.
Kruzel-Davila E; Wasser WG; Skorecki K
Semin Nephrol; 2017 Nov; 37(6):490-507. PubMed ID: 29110756
[TBL] [Abstract][Full Text] [Related]
24. Optimal management of HIV- positive adults at risk for kidney disease in Nigeria (Renal Risk Reduction "R3" Trial): protocol and study design.
Aliyu MH; Wudil UJ; Ingles DJ; Shepherd BE; Gong W; Musa BM; Muhammad H; Sani MU; Abdu A; Nalado AM; Atanda A; Ahonkhai AA; Ikizler TA; Winkler CA; Kopp JB; Kimmel PL; Wester CW
Trials; 2019 Jun; 20(1):341. PubMed ID: 31182139
[TBL] [Abstract][Full Text] [Related]
25. Impact of
An P; Kirk GD; Limou S; Binns-Roemer E; Kopp JB; Winkler CA
Front Immunol; 2019; 10():53. PubMed ID: 30733721
[TBL] [Abstract][Full Text] [Related]
26.
Chaudhary NS; Moore JX; Zakai NA; Judd SE; Naik RP; Limou S; Cushman M; Lange LA; Wang HE; Winkler CA; Irvin MR; Kopp JB; Gutiérrez OM
Clin J Am Soc Nephrol; 2019 Dec; 14(12):1733-1740. PubMed ID: 31704668
[TBL] [Abstract][Full Text] [Related]
27. AKI and Collapsing Glomerulopathy Associated with COVID-19 and
Wu H; Larsen CP; Hernandez-Arroyo CF; Mohamed MMB; Caza T; Sharshir M; Chughtai A; Xie L; Gimenez JM; Sandow TA; Lusco MA; Yang H; Acheampong E; Rosales IA; Colvin RB; Fogo AB; Velez JCQ
J Am Soc Nephrol; 2020 Aug; 31(8):1688-1695. PubMed ID: 32561682
[TBL] [Abstract][Full Text] [Related]
28. Association of APOL1 Genotype with Renal Histology among Black HIV-Positive Patients Undergoing Kidney Biopsy.
Atta MG; Estrella MM; Skorecki KL; Kopp JB; Winkler CA; Wasser WG; Shemer R; Racusen LC; Kuperman M; Foy MC; Lucas GM; Fine DM
Clin J Am Soc Nephrol; 2016 Feb; 11(2):262-70. PubMed ID: 26668025
[TBL] [Abstract][Full Text] [Related]
29. Association of Genetic Polymorphisms of TGF-β1, HMOX1, and APOL1 With CKD in Nigerian Patients With and Without HIV.
Ekrikpo UE; Mnika K; Effa EE; Ajayi SO; Okwuonu C; Waziri B; Bello A; Dandara C; Kengne AP; Wonkam A; Okpechi I
Am J Kidney Dis; 2020 Jul; 76(1):100-108. PubMed ID: 32354559
[TBL] [Abstract][Full Text] [Related]
30. APOL1 risk variants and the development of HIV-associated nephropathy.
Goyal R; Singhal PC
FEBS J; 2021 Oct; 288(19):5586-5597. PubMed ID: 33340240
[TBL] [Abstract][Full Text] [Related]
31. JC polyoma virus interacts with APOL1 in African Americans with nondiabetic nephropathy.
Divers J; Núñez M; High KP; Murea M; Rocco MV; Ma L; Bowden DW; Hicks PJ; Spainhour M; Ornelles DA; Kleiboeker SB; Duncan K; Langefeld CD; Turner J; Freedman BI
Kidney Int; 2013 Dec; 84(6):1207-13. PubMed ID: 23677244
[TBL] [Abstract][Full Text] [Related]
32. Apolipoprotein L1 High-Risk Genotypes and Albuminuria in Sub-Saharan African Populations.
Brandenburg JT; Govender MA; Winkler CA; Boua PR; Agongo G; Fabian J; Ramsay M
Clin J Am Soc Nephrol; 2022 Jun; 17(6):798-808. PubMed ID: 35577564
[TBL] [Abstract][Full Text] [Related]
33.
Friedman DJ; Pollak MR
Annu Rev Physiol; 2020 Feb; 82():323-342. PubMed ID: 31710572
[TBL] [Abstract][Full Text] [Related]
34. Population genetics of chronic kidney disease: the evolving story of APOL1.
Wasser WG; Tzur S; Wolday D; Adu D; Baumstein D; Rosset S; Skorecki K
J Nephrol; 2012; 25(5):603-18. PubMed ID: 22878977
[TBL] [Abstract][Full Text] [Related]
35. Phenome-wide analysis reveals epistatic associations between APOL1 variants and chronic kidney disease and multiple other disorders.
Adamson WE; Noyes H; Johnson P; Cooper A; Monckton DG; Ogunsola J; Beckett-Hill G; Sullivan M; Mark P; Parekh RS; MacLeod A
EBioMedicine; 2024 Mar; 101():105000. PubMed ID: 38360481
[TBL] [Abstract][Full Text] [Related]
36. An investigation of APOL1 risk genotypes and preterm birth in African American population cohorts.
Robertson CC; Gillies CE; Putler RKB; Ng D; Reidy KJ; Crawford B; Sampson MG
Nephrol Dial Transplant; 2017 Dec; 32(12):2051-2058. PubMed ID: 27638911
[TBL] [Abstract][Full Text] [Related]
37. Clinical and Genetic Characteristics of CKD Patients with High-Risk APOL1 Genotypes.
Elliott MD; Marasa M; Cocchi E; Vena N; Zhang JY; Khan A; Krishna Murthy S; Bheda S; Milo Rasouly H; Povysil G; Kiryluk K; Gharavi AG
J Am Soc Nephrol; 2023 May; 34(5):909-919. PubMed ID: 36758113
[TBL] [Abstract][Full Text] [Related]
38. Target organ damage in African American hypertension: role of APOL1.
Freedman BI; Murea M
Curr Hypertens Rep; 2012 Feb; 14(1):21-8. PubMed ID: 22068337
[TBL] [Abstract][Full Text] [Related]
39. APOL1 polymorphisms and kidney disease: loss-of-function or gain-of-function?
Bruggeman LA; O'Toole JF; Sedor JR
Am J Physiol Renal Physiol; 2019 Jan; 316(1):F1-F8. PubMed ID: 30332315
[TBL] [Abstract][Full Text] [Related]
40. Examination of Potential Modifiers of the Association of APOL1 Alleles with CKD Progression.
Chen TK; Choi MJ; Kao WH; Astor BC; Scialla JJ; Appel LJ; Li L; Lipkowitz MS; Wolf M; Parekh RS; Winkler CA; Estrella MM; Crews DC
Clin J Am Soc Nephrol; 2015 Dec; 10(12):2128-35. PubMed ID: 26430087
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
